Publication | Closed Access

Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen

Prognostic FactorsNeuro-oncologyMedicineRecurrent Glioblastoma MultiformeImmune Checkpoint InhibitorNeurologyHigh-grade GliomasLimited ImpactCancer TreatmentRadiation OncologyOncologyGliomaGlioblastoma